A new study focused on transcription-replication conflicts, which occur when mechanisms responsible for gene expression and ...

Editor’s note: This is an automatically generated transcript. Please notify [email protected] if there are concerns regarding accuracy of the transcription.

AbbeGen, a next-generation early-stage biopharmaceutical company founded by Nigerian-American venture capitalist and businessman Joshua Oduyemi, is pioneering a global movement in the fight against ...

Several studies have been conducted, but questions remain about where such therapies will fit into multiple myeloma treatment ...

Engine Biosciences (Engine), a Singapore- and Silicon Valley-based biotechnology company pioneering precision medicine for ...

Dr. Valerie Lee discussed emerging targeted therapies and personalized medicine approaches that are showing promise for those with gastrointestinal cancer.

Pat Gulhati, MD, PhD, discusses findings from a comprehensive analysis of genetic, immunological, and signaling pathway variations in pancreatic cancer.

In immune-mediated inflammatory diseases, the overall risk for serious adverse events is not notably higher with combo ...

In an effort to find new treatments for castrate-resistant prostate cancer, a TTUHSC research team led by Srinivas Nandana, ...

Voices of Hope donated more than $100,000 earlier this month to the Massachusetts General Hospital Cancer Center’s Termeer ...

The GI Cancers Symposium revealed new therapies for specific cancer subsets and progress in chimeric antigen receptor T-cell ...